BRIEF-Mallinckrodt says first patient enrolled in phase 4 trial of H.P. Acthar gel for rare cause of nephrotic syndrome

* First patient enrolled in mallinckrodt phase 4 trial of

h.p. acthar gel for rare cause of nephrotic syndrome

Source text for Eikon:

Further company coverage:

)

Read more